Evidence map›Paper›PMID 37622717›Full record

ReviewCurrent drug research reviews2024

A Review on Exploring the Potential of Vincamine and

Rizwana Bee, Mohammad Ahmad, Shashi Verma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug research reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rizwana BeeShri Ram Murti Smarak College of Engineering & Technology (Pharmacy) Bareilly, Uttar Pradesh, 243202, India.
Mohammad AhmadDepartment of Pharmacy, Integral University Lucknow, Lucknow, India.
Shashi VermaDepartment of Pharmaceutics, Shri Ram Murti Smarak College of Engineering & Technology (Pharmacy) Bareilly, Uttar Pradesh, 243202, India.
Integral University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepression is a prevalent psychiatric disorder and one of the leading causes of disability around the world. Herbal and synthetic medications used to treat depression, may interrupt the therapy process and cause adverse effects. Currently, the use of medicinal and phytochemical plants, which have various therapeutic effects and has potential strategy for treating depression. According to the studies, medicinal plants have a variety of effects on the brain system and have antidepressant properties such as synaptic modulation of serotonin, noradrenalin and dopamine as well as inflammatory mediators. According to the literature review,

objectivesThe main aim of the present study is to gather data from the literature review regarding the antidepressant activity of

methodsAccording to the review antidepressant activity of various medications can be tested using two different types of studies, including

resultsClinical and preclinical research suggests that one of the main mediators in the pathophysiology of depression seems to be stress. Depression can be evaluated using experimental methods based on a variety of physical indicators, including locomotor activity, rearing, faeces, and the quantity of entries in the centre square (

conclusionAccording to the Globe Health Organization, depression will become the most common cause of loss of interest in working in the world. As a result, depression research is one of the most significant ways in which we might create new treatments in the form of

Indexed as

Antidepressive AgentsDepressionMelatoninVincamineAnimalsHumansPlant ExtractsAntidepressive AgentsMelatoninPlant ExtractsVincaminebiomarkersDepressionmelatoninnoradrenalineserotoninvincamineWHO.

Identifiers

PMID37622717
OpenAlexW4386151650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.